1. Home
  2. BNTC vs UROY Comparison

BNTC vs UROY Comparison

Compare BNTC & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • UROY
  • Stock Information
  • Founded
  • BNTC 1995
  • UROY 2017
  • Country
  • BNTC United States
  • UROY Canada
  • Employees
  • BNTC N/A
  • UROY N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • UROY
  • Sector
  • BNTC Health Care
  • UROY
  • Exchange
  • BNTC Nasdaq
  • UROY Nasdaq
  • Market Cap
  • BNTC 335.5M
  • UROY 336.8M
  • IPO Year
  • BNTC N/A
  • UROY N/A
  • Fundamental
  • Price
  • BNTC $13.24
  • UROY $3.15
  • Analyst Decision
  • BNTC Strong Buy
  • UROY Strong Buy
  • Analyst Count
  • BNTC 5
  • UROY 2
  • Target Price
  • BNTC $26.00
  • UROY $4.00
  • AVG Volume (30 Days)
  • BNTC 40.8K
  • UROY 2.6M
  • Earning Date
  • BNTC 09-25-2025
  • UROY 07-16-2025
  • Dividend Yield
  • BNTC N/A
  • UROY N/A
  • EPS Growth
  • BNTC N/A
  • UROY N/A
  • EPS
  • BNTC N/A
  • UROY N/A
  • Revenue
  • BNTC N/A
  • UROY $11,285,840.00
  • Revenue This Year
  • BNTC N/A
  • UROY $228.36
  • Revenue Next Year
  • BNTC N/A
  • UROY N/A
  • P/E Ratio
  • BNTC N/A
  • UROY N/A
  • Revenue Growth
  • BNTC N/A
  • UROY N/A
  • 52 Week Low
  • BNTC $8.06
  • UROY $1.43
  • 52 Week High
  • BNTC $17.15
  • UROY $3.30
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 59.72
  • UROY 65.88
  • Support Level
  • BNTC $12.57
  • UROY $2.51
  • Resistance Level
  • BNTC $13.33
  • UROY $2.87
  • Average True Range (ATR)
  • BNTC 0.60
  • UROY 0.16
  • MACD
  • BNTC 0.10
  • UROY 0.05
  • Stochastic Oscillator
  • BNTC 95.59
  • UROY 82.05

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About UROY Uranium Royalty Corp.

Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.

Share on Social Networks: